MSD AH: T. suis product, European approval
MSD Animal Health (known as Merck Animal Health in USA and Canada) announced the European approval of a new indication for Panacur AquaSol (fenbendazole 200 mg/mL) to effectively treat swine infected with Trichuris suis (T. suis), a whipworm found worldwide that causes multifocal inflammation. Heavy infections often cause diarrhea and emaciation.
Panacur AquaSol is a dewormer for swine administered through drinking water that stays in suspension without re‐stirring, ensuring more uniform intake and proper dosing of the field‐proven anthelmintic. In a single‐site, dose confirmation study conducted at a German University, Panacur AquaSol was found to be significantly efficacious (93% worm count reduction) in the treatment of swine naturally infected with T. suis when compared to an untreated control group. Panacur AquaSol was well tolerated by the study animals.
“The infestation of T. suis in swine can have a significant economic impact for swine producers, if not treated quickly and effectively,” stated Dr. Alex Eggen, Director, MSD Animal Health. “The innovative wet‐milling process for Panacur AquaSol produces very fine particles that mix easily in water and stay suspended for 24 hours without agitation, making treatment for T. suis easy and effective and that is highly desirable for especially those producers that use outdoor production facilities.”
Panacur AquaSol, which can be used in weaners, growers, gestating sows and boars, is also indicated for the treatment and control of infections with Ascaris suum (adult, intestinal and migrating larval stages) and Oesophagostomum spp. (adult stages). The applied dose regimen is a daily dose of 2.5 mg fenbendazole (FBZ)/kg bodyweight (BW) for 2 consecutive days for a total dose of 5 mg FBZ/kg BW. ForT. suis infections, the applied dose regimen is a daily dose of 2.5 mg FBZ/kg BW for 3 consecutive days, for a total dose of 7.5 mg FBZ/kg BW.
